NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
ID: 343474Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/343474

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-22-225.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), is inviting proposals for investigator-initiated Program Project (P01) applications focused on critical research areas related to infectious diseases and immune-mediated conditions. Applicants are required to submit proposals that include at least two related research projects sharing a common theme, along with an administrative core, while clinical trials are not permitted under this funding opportunity. This initiative aims to enhance collaborative research efforts to address significant health challenges, including the biology of infectious microbes and the development of vaccines and therapeutics. Interested applicants can find more information and submission guidelines at the provided link, with the next application deadlines set for January 11 and June 8, 2023, and a final close date of September 7, 2025. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-22-225-Full-Announcement.html
    PAR-22-225.html
    The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), invites proposals for investigator-initiated Program Project (P01) applications focused on critical research areas. The funding aims to address topics like infectious disease mechanisms, immune system interactions, and translational research for therapeutics and diagnostics. Each application must include at least two related research projects with a shared central theme, along with an administrative core. Clinical trials are prohibited under this funding announcement. Key application deadlines include January 11 and June 8 for non-AIDS projects in 2023, with multiple review dates extending into 2026. The application process requires compliance with detailed submission guidelines, including registrations with Grants.gov, SAM, and eRA Commons. NIH emphasizes the importance of integrated research efforts to achieve significant scientific advancements compared to isolated studies. Reviews will consider the overall impact, significance, innovation, and coordination of projects. The announcement reflects NIH's ongoing commitment to enhance research capabilities in infectious and immune-mediated diseases, ensuring a collaborative and multidisciplinary approach to health research.
    Similar Opportunities
    NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Allergy and Infectious Diseases (NIAID), is offering a funding opportunity for investigator-initiated Resource-Related Research Projects (R24), specifically excluding clinical trials. This initiative aims to enhance existing high-priority research by supporting resources that provide critical data, materials, tools, or services beneficial to the scientific community, particularly in areas related to immunology and infectious diseases. Eligible applicants include a diverse range of institutions, such as higher education and nonprofit organizations, with proposals due by January 7, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-065.html.
    National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health, through the National Cancer Institute (NCI), invites applications for Program Project grants (P01) aimed at fostering collaborative, multidisciplinary cancer research for the years 2023, 2024, and 2025. Applicants must propose at least three interrelated research projects and an Administrative Core, all centered around a common theme within the expansive field of cancer research, which includes areas such as cancer biology, prevention, diagnosis, treatment, and control. This funding opportunity is crucial for advancing cancer research and enhancing the effectiveness of collaborative efforts, with applications due by May 7, 2026. Interested parties can find more information and application guidelines at the provided link, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.
    NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is inviting applications for Program Project Grants (P01 Clinical Trial Optional) aimed at fostering collaborative, multidisciplinary research on substance use disorders. Applicants must propose a minimum of three interrelated research projects that demonstrate scientific and administrative synergy under a unifying theme, addressing critical issues such as neuroscience, genetics, behavior, prevention, treatment, and health services related to substance use. This funding opportunity emphasizes inclusivity, requiring a Plan for Enhancing Diverse Perspectives (PEDP) and encouraging participation from underrepresented groups, with a maximum project duration of five years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by January 7, 2026.
    NHLBI Program Project Applications (P01 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI), has announced a funding opportunity for Program Project (P01) grant applications aimed at advancing research in heart, lung, and blood diseases. Applicants are required to submit proposals that include a minimum of three interrelated research projects focused on a common biomedical theme, with the option to incorporate clinical trials. This initiative is designed to foster collaborative research efforts and encourage innovative scientific directions, particularly supporting projects led by Early Stage Investigators (ESIs). The maximum funding for awarded projects is capped at $1.515 million annually, or $1.765 million if an ESI-led project is included, with a project duration of up to five years. Interested applicants can find more information and submit their proposals electronically via Grants.gov, with a closing date for applications set for September 25, 2026. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering a funding opportunity titled "Priority HIV/AIDS Research" under the R01 grant mechanism. This initiative aims to stimulate research that aligns with NIH’s priorities regarding HIV/AIDS, particularly focusing on systemic complications such as metabolic, gastrointestinal, and kidney issues arising from HIV, while encouraging the incorporation of health-impeding social determinants of health into research proposals. The anticipated funding amount is $2 million, with plans to support 3 to 5 awards over five years, and applications are due starting May 7, 2025. Interested applicants can find more information and application guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Co-infection and Cancer (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Co-infection and Cancer (R01 Clinical Trial Not Allowed)" aimed at enhancing the understanding of infection-related cancers, particularly the roles of co-infections with multiple pathogens, excluding HIV. This initiative seeks to investigate the mechanisms and epidemiology of cancer linked to various infectious agents, addressing significant gaps in the current understanding of cancer etiology, with a focus on health disparities in underrepresented populations. Eligible applicants include a wide range of entities such as higher education institutions, nonprofits, and foreign organizations, with no budget limit for applications, although strong preliminary data is required. Key deadlines include an earliest submission date of January 5, 2025, and a close date of January 7, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-082.html.
    Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the grant opportunity titled "Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK." This funding initiative aims to support innovative pilot research projects that explore the biological, behavioral, and social mechanisms related to HIV pathogenesis, particularly focusing on comorbidities and complications affecting organs and tissues relevant to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The research is expected to enhance understanding of the interplay between HIV and associated health issues, with a funding cap of $275,000 over two years for successful applications. Interested applicants, including higher education institutions and various nonprofit organizations, should note that the application deadlines begin in April 2025, with the final submission date set for January 7, 2028. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Understanding Mechanisms and Outcomes of Trained Immunity" (FO No. PAR-24-112) aimed at enhancing research on innate immune memory. This initiative seeks to support studies that identify biomarkers of trained immunity, elucidate underlying molecular mechanisms, and assess the implications for immune system function, particularly in relation to vaccines, infections, and autoimmune or allergic diseases. The funding is crucial for advancing immunological research with significant public health implications, and applications are due by June 5, 2024, and October 5, 2024. Interested applicants can find more information and submit their proposals via Grants.gov, and for inquiries, they may contact NIH Grants Information at grantsinfo@nih.gov.
    NIAID Resource-Related Research Projects
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "NIAID Resource-Related Research Projects," aimed at supporting investigator-initiated research that develops essential resources for biomedical research. This program encourages small businesses to propose non-hypothesis-driven activities that provide high-quality data, materials, tools, or services relevant to the NIAID mission, which includes areas such as infectious diseases, immune function, and translational research for vaccines and therapeutics. Interested applicants should note that there is no cost-sharing requirement, and the estimated synopsis close date is January 26, 2026, with awards expected to be made by December 1, 2026. For further inquiries, applicants can contact Dr. Chelsea Boyd at chelsea.boyd@nih.gov or by phone at 301-761-6664.
    Influenza Transmission Research Consortium (P01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity titled "Influenza Transmission Research Consortium (P01 Clinical Trial Optional)" aimed at advancing research on the mechanisms of human-to-human transmission of seasonal influenza virus. This initiative seeks to establish a network of Influenza Transmission Research Centers that will foster collaborative, multidisciplinary teams to investigate the dynamics and drivers of influenza transmission, ultimately developing novel resources for the field of respiratory virus transmission. With an estimated total program funding of $8 million and the expectation of awarding three grants, interested applicants are encouraged to begin forming collaborations and preparing their proposals ahead of the anticipated application solicitation, which is expected to open in September 2025. For further inquiries, potential applicants can contact Brooke Bozick, Ph.D., at brooke.bozick@mail.nih.gov or by phone at 301-761-6710.